Deep Track Capital, LP Allakos Inc. Transaction History
Deep Track Capital, LP
- $2.71 Billion
- Q3 2024
A detailed history of Deep Track Capital, LP transactions in Allakos Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 5,000,000 shares of ALLK stock, worth $6 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
5,000,000
Previous 5,000,000
-0.0%
Holding current value
$6 Million
Previous $5 Million
35.0%
% of portfolio
0.12%
Previous 0.16%
Shares
6 transactions
Others Institutions Holding ALLK
# of Institutions
81Shares Held
64.7MCall Options Held
47.1KPut Options Held
1K-
Bvf Inc San Francisco, CA16.6MShares$19.9 Million0.34% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$7.38 Million0.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$4.22 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA3.08MShares$3.69 Million0.13% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.96MShares$3.55 Million0.28% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $102M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...